NHS National Framework for Tocilizumab - March 2024

Concepts

• runcorn
• pharmaceutical products
• nhs national framework
• tocilizumab north
• tocilizumab london
• cm/phr/23/5702/02 nhs framework
• project title: nhs national framework
• /phr/23/5702/01 nhs framework
• cm/phr/23/5702 cm/phr/23/5702/01 nhs framework
• tocilizumab - march

Location

Geochart for 1 buyers and 0 suppliers

NHS England

+−

Leaflet | Map tiles by Stamen Design, under CC BY 3.0. Data by OpenStreetMap, under ODbL.

Description

Project Title: NHS National Framework for Tocilizumab - March 2024 Offer reference number: CM/PHR/23/5702 CM/PHR/23/5702/01 NHS Framework for Tocilizumab LONDON and SOUTH OF ENGLAND. Period of framework: 1 March 2024 to 28 February 2025 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 24 months. CM/PHR/23/5702/02 NHS Framework for Tocilizumab NORTH OF ENGLAND and MIDLANDS AND EAST. Period of framework: 1 March 2024 to 28 February 2025 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 24 months.

CPV Codes

• 33600000 - Pharmaceutical products

Indicators

• Contract is suitable for SMEs.

Other Information

To express interest and participate in the tender, please register and apply via Atamis e-sourcing portal https://health-family.force.com/s/Welcome. Should Tenderers have any queries, or having problems using the portal, they should contact Helpdesk at: Phone: 0800 9956035 E-mail: support-health@atamis.co.uk Document No. 04a - Quality Assurance Process Document No. 04a - Quality Assurance Process.pdf Document No. 04b - Assessment Criteria, Stability Protocol and Additional Specification Requirements Document No. 04b - Assessment Criteria, Stability Protocol and Additional Specification Requirements.pdf Document No. 05 - Selectt offer schedule instructions CM-PHR-23-5702 Document No. 05 - Selectt offer schedule instructions CM-PHR-23-5702.docx Document No. 05a - Selectt Offer schedule - CM_PHR_23_5702_01 Document No. 05a - Selectt Offer schedule - CM_PHR_23_5702_01.xml Document No. 02 - Terms of offer Document No. 02 - Terms of offer.docx Document No. 05a - Selectt Offer schedule - CM_PHR_23_5702_02 Document No. 05a - Selectt Offer schedule - CM_PHR_23_5702_02.xml Document No. 05b (i) - Tender Product listing and usage CM_PHR_23_5702_01 Document No. 05b (i) - Tender Product listing and usage CM_PHR_23_5702_01.xlsx Document No. 01 - Invitation to offer covering letter CM-PHR-23-5702 Document No. 01 - Invitation to offer covering letter CM-PHR-23-5702.docx Document No. 03 - Framework Agreement and Terms and Conditions Document No. 03 - Framework Agreement and Terms and Conditions.pdf Document No. 05b (ii) - Tender Product listing and usage CM_PHR_23_5702_02 Document No. 05b (ii) - Tender Product listing and usage CM_PHR_23_5702_02.xlsx Document No. 08 - Confidential information schedule CM-PHR-23-5702 Document No. 08 - Confidential information schedule CM-PHR-23-5702.xls Document No.10 - Pharmacy Purchasing Points CM-PHR-23-5702 Document No.10 - Pharmacy Purchasing Points CM-PHR-23-5702.xlsx Document No. 06 - Form of offer CM-PHR-23-5702 Document No. 06 - Form of offer CM-PHR-23-5702.doc Document No. 09 - Tender design and instructions on completing the offer schedule Document No. 09 - Tender design and instructions on completing the offer schedule.doc Document No. 07a - Quality control technical sheet Document No. 07a - Quality control technical sheet.pdf Document No. 07b - Quality Assurance Policy to support the National Contract Procurement of Licensed Medicines v6 (Issued October 2023) Document No. 07b - Quality Assurance Policy to support the National Contract Procurement of Licensed Medicines v6 (Issued October 2023).pdf